Jan 12, 2021 8:30am EST Sigyn Therapeutics (SIGY) CEO Note: Overcoming the Limitations of Previous Cytokine Storm Treatment Strategies
Jan 06, 2021 8:30am EST Sigyn Therapeutics™ Reports Results of Pilot Study to Address Inflammatory CytoVesicles
Dec 01, 2020 8:45am EST Sigyn Therapeutics™ Reports Simultaneous Clearance of Endotoxin and Inflammatory Cytokines From Human Blood Plasma
Nov 02, 2020 7:30am EST Sigyn Therapeutics (SIGY) CEO Note: Rethinking the Treatment of Sepsis and Other Life-Threatening Inflammatory Conditions
